Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Kite Pharma
Biotech
ASH: Gilead-Arcellx data build CAR-T's case in advanced myeloma
Arcellx's new data on a Gilead-partnered CAR-T show durable results and best-in-class potential for advanced multiple myeloma, analysts said.
Gabrielle Masson
Nov 5, 2024 3:08pm
2 Kite vets fly over to Kyverna Therapeutics—Chutes & Ladders
Sep 20, 2024 8:30am
J&J, Bayer, Santa Ana, Regenxbio and more—Chutes & Ladders
Jun 14, 2024 8:30am
Ex-Kite leader helms Santa Ana’s ship with $168M in hand
Jun 13, 2024 8:00am
How to get cell therapies flying off-the-shelf
May 31, 2024 9:00am
Cell therapy reckoning: An unmet need remains in oncology
May 30, 2024 10:00am
